ArticleBritish journal of cancer2026

Furmonertinib combined with bevacizumab in EGFR-TKI-resistant leptomeningeal metastasis: analysis of the CSF ctDNA molecular response and survival outcomes.

Xiaoyue Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.